全文获取类型
收费全文 | 2528篇 |
免费 | 174篇 |
国内免费 | 28篇 |
专业分类
耳鼻咽喉 | 18篇 |
儿科学 | 99篇 |
妇产科学 | 73篇 |
基础医学 | 275篇 |
口腔科学 | 91篇 |
临床医学 | 272篇 |
内科学 | 637篇 |
皮肤病学 | 36篇 |
神经病学 | 148篇 |
特种医学 | 323篇 |
外国民族医学 | 3篇 |
外科学 | 275篇 |
综合类 | 36篇 |
一般理论 | 1篇 |
预防医学 | 179篇 |
眼科学 | 30篇 |
药学 | 153篇 |
肿瘤学 | 81篇 |
出版年
2022年 | 19篇 |
2021年 | 29篇 |
2020年 | 10篇 |
2019年 | 34篇 |
2018年 | 50篇 |
2017年 | 23篇 |
2016年 | 30篇 |
2015年 | 45篇 |
2014年 | 57篇 |
2013年 | 80篇 |
2012年 | 127篇 |
2011年 | 104篇 |
2010年 | 78篇 |
2009年 | 75篇 |
2008年 | 88篇 |
2007年 | 118篇 |
2006年 | 115篇 |
2005年 | 96篇 |
2004年 | 68篇 |
2003年 | 79篇 |
2002年 | 67篇 |
2001年 | 63篇 |
2000年 | 51篇 |
1999年 | 72篇 |
1998年 | 82篇 |
1997年 | 89篇 |
1996年 | 95篇 |
1995年 | 56篇 |
1994年 | 50篇 |
1993年 | 55篇 |
1992年 | 44篇 |
1991年 | 47篇 |
1990年 | 46篇 |
1989年 | 75篇 |
1988年 | 68篇 |
1987年 | 50篇 |
1986年 | 56篇 |
1985年 | 46篇 |
1984年 | 22篇 |
1983年 | 22篇 |
1982年 | 19篇 |
1981年 | 19篇 |
1980年 | 20篇 |
1978年 | 13篇 |
1977年 | 23篇 |
1976年 | 19篇 |
1975年 | 14篇 |
1974年 | 10篇 |
1973年 | 15篇 |
1972年 | 11篇 |
排序方式: 共有2730条查询结果,搜索用时 31 毫秒
91.
Bjoern Moosmann Philippe Bisel Folker Westphal Maurice Wilde Jürgen Kempf Verena Angerer Volker Auwrter 《Drug testing and analysis》2019,11(3):541-549
The number of newly appearing benzodiazepine derivatives on the new psychoactive substances (NPS) drug market has increased over the last couple of years totaling 23 ‘designer benzodiazepines’ monitored at the end of 2017 by the European Monitoring Centre for Drugs and Drug Addiction. In the present study, three benzodiazepines [flunitrazolam, norflurazepam, and 4′‐chlorodiazepam (Ro5–4864)] offered as ‘research chemicals' on the Internet were characterized and their main in vitro phase I metabolites tentatively identified after incubation with pooled human liver microsomes. For all compounds, the structural formula declared by the vendor was confirmed by gas chromatography?mass spectrometry (GC–MS), liquid chromatography?tandem mass spectrometry (LC MS/MS), liquid chromatography?quadrupole time of flight?mass spectrometry (LC?QTOF?MS) analysis and nuclear magnetic resonance (NMR) spectroscopy. The metabolic steps of flunitrazolam were monohydroxylation, dihydroxylation, and reduction of the nitro function. The detected in vitro phase I metabolites of norflurazepam were hydroxynorflurazepam and dihydroxynorflurazepam. 4’‐Chlorodiazepam biotransformation consisted of N‐dealkylation and hydroxylation. It has to be noted that 4′‐chlorodiazepam and its metabolites show almost identical LC–MS/MS fragmentation patterns to diclazepam and its metabolites (delorazepam, lormetazepam, and lorazepam), making a sufficient chromatographic separation inevitable. Sale of norflurazepam, the metabolite of the prescribed benzodiazepines flurazepam and fludiazepam, presents the risk of incorrect interpretation of analytical findings. 相似文献
92.
Renal transplantation increases survival and quality of life of patients with end-stage renal failure. The development of new immunosuppressive agents has led to new therapeutic strategies and to significant reduction of episodes with acute allograft rejection. However, the long-term outcome of patients after renal transplantation did not improve to the same extent. Biologics are nowadays used routinely in renal transplantation. Induction therapy which is based on biologics improves survival and decreases the risk of acute rejection. Blockade of costimulation inhibiting T-cell activation could allow calcineurin inhibitor (CNI)-free long-term immunosuppression as has been recently demonstrated in the randomized multicenter BENEFIT trial. Biologics are important therapeutic agents to treat acute rejection. Steroid-resistant cellular rejection should be treated with lymphocyte-depleting biologics. In cases of humoral rejection, B-cell depleting agents may be considered. Complement blockade can be an alternative therapeutic option in patients with a refractory course of disease. In summary, biologics are potent and effective agents to complement the standard immunosuppressive therapy with CNI, mycophenolate mofetil and steroids. 相似文献
93.
ILR Genetics Consortium Emerging Risk Factors Collaboration Sarwar N Butterworth AS Freitag DF Gregson J Willeit P Gorman DN Gao P Saleheen D Rendon A Nelson CP Braund PS Hall AS Chasman DI Tybjærg-Hansen A Chambers JC Benjamin EJ Franks PW Clarke R Wilde AA Trip MD Steri M Witteman JC Qi L van der Schoot CE de Faire U Erdmann J Stringham HM Koenig W Rader DJ Melzer D Reich D Psaty BM Kleber ME Panagiotakos DB Willeit J Wennberg P Woodward M Adamovic S Rimm EB Meade TW Gillum RF Shaffer JA 《Lancet》2012,379(9822):1205-1213
94.
Spranger S Jeremias I Wilde S Leisegang M Stärck L Mosetter B Uckert W Heemskerk MH Schendel DJ Frankenberger B 《Blood》2012,119(15):3440-3449
The hyaluronan-mediated motility receptor (HMMR/Rhamm) is overexpressed in numerous tumor types, including acute lymphoid leukemia and acute myeloid leukemia (AML). Several studies have reported the existence of T-cell responses directed against HMMR in AML patients that are linked to better clinical outcome. Therefore, we explored the use of HMMR-specific TCRs for transgenic expression in lymphocytes and their in vivo impact on HMMR(+) solid tumors and disseminated leukemia. We obtained TCRs via an in vitro priming approach in combination with CD137-mediated enrichment. Recipient lymphocytes expressing transgenic TCR revealed the specific tumor recognition pattern seen with the original T cells. Adoptive transfer experiments using a humanized xenograft mouse model resulted in significantly retarded solid tumor outgrowth, which was enhanced using IL-15-conditioned, TCR-transgenic effector memory cells. These cells also showed an increased potency to retard the outgrowth of disseminated AML, and this was further improved using CD8-enriched effector memory cells. To define a safe clinical setting for HMMR-TCR gene therapy, we analyzed transgenic T-cell recognition of hematopoietic stem cells (HSCs) and found on-target killing of HLA-A2(+) HSCs. Our findings clearly limit the use of HMMR-TCR therapy to MHC- mismatched HSC transplantation, in which HLA-A2 differences can be used to restrict recognition to patient HSCs and leukemia. 相似文献
95.
96.
Oral Diseases (2012) 19 , 46–58 Sjögren’s syndrome (SjS) is one of the most common autoimmune rheumatic diseases, clinically characterized by xerostomia and keratoconjunctivitis sicca. We investigated the following controversial topics: (i) Do we have reliable ways of assessing saliva production? (ii) How important are the quantity and quality of saliva? (iii) Are only anti‐SSA/Ro and anti‐SSB/La relevant for the diagnosis of SjS? (iv) Are the American‐European Consensus criteria (AECC) the best way to diagnose SjS? Results from literature searches suggested the following: (i) Despite the fact that numerous tests are available to assess salivation rates, direct comparisons among them are scarce with little evidence to suggest one best test. (ii) Recent developments highlight the importance of investigating the composition of saliva. However, more research is needed to standardize the methods of analysis and collection and refine the quality of the accumulating data. (iii) In addition to anti‐Ro/La autoantibodies, anti α‐fodrin IgA and anti‐MR3 autoantibodies seem to be promising diagnostic markers of SjS, but more studies are warranted to test their sensitivity and specificity. (iv) AECC are classification, not diagnostic criteria. Moreover, recent innovations have not been incorporated into these criteria. Consequently, treatment directed to patients diagnosed using the AECC might exclude a significant proportion of patients with SjS. 相似文献
97.
98.
J Tang DJ Humes E Gemmil NT Welch SL Parsons JA Catton 《Annals of the Royal College of Surgeons of England》2013,95(5):323-328
Introduction
The high mortality and morbidity associated with resection for oesophagogastric malignancy has resulted in a conservative approach to the postoperative management of this patient group. In August 2009 we introduced an enhanced recovery after surgery (ERAS) pathway tailored to patients undergoing resection for oesophagogastric malignancy. We aimed to assess the impact of this change in practice on standard clinical outcomes.Methods
Two cohorts were studied of patients undergoing resection for oesophagogastric malignancy before (August 2008 – July 2009) and after (August 2009 – July 2010) the implementation of the ERAS pathway. Data were collected on demographics, interventions, length of stay, morbidity and in-hospital mortality.Results
There were 53 and 55 oesophagogastric resections undertaken respectively for malignant disease in each of the study periods. The median length of stay for both gastric and oesophageal resection decreased from 15 to 11 days (Mann– Whitney U, p<0.001) following implementation of the ERAS pathway. There was no significant increase in morbidity (gastric resection 23.1% vs 5.3% and oesophageal resection 25.9% vs 16.7%) or mortality (gastric resection no deaths and oesophageal resection 1.8% vs 3.6%) associated with the changes. There was a significant decrease in the number of oral contrast studies used following oesophageal resection, with a reduction from 21 (77.8%) in 2008–2009 to 6 (16.7%) in 2009–2010 (chi-squared test, p<0.0001).Conclusions
The introduction of an enhanced recovery programme following oesophagogastric surgery resulted in a significant decrease in length of median patient stay in hospital without a significant increase in associated morbidity and mortality. 相似文献99.
Affective Decision-Making Is Predictive of Three-Month Relapse in Polysubstance-Dependent Alcoholics
Background/Aims: Common and long-lasting deficits in decision-making in polysubstance-dependent alcoholics (PSA) reflect neurobiological alterations that define the chronic nature of addiction. These deficits affect goal-directed behavior and might be critical risk factors predicting relapse in PSA. Methods: The Delay Discounting Task (DDT) and the Iowa Gambling Task (IGT) assessed the delay-discounting and decision-making skills among 37 abstinent PSA. Results: The findings indicated that IGT but not DDT performances were associated with 3-month abstinence, irrespective of the influence of personality traits and coexistent medications. Conclusion: The results show that the IGT, which assesses processes that are important in the latter stages of addiction, is ecologically more valid compared to the DDT, which assesses processes important in the early stages. They underline the importance of using neurocognitive measures to identify high relapse risk patients and emphasize the relevance of promoting new treatments. 相似文献
100.